| 1. |
|
|
| 2. |
|
|
| 3. |
|
|
| 4. |
|
|
| 5. |
|
|
| 6. |
|
|
| 7. |
- Buffart, L. M., et al.
(författare)
-
Effects and moderators of coping skills training on symptoms of depression and anxiety in patients with cancer : Aggregate data and individual patient data meta-analyses
- 2020
-
Ingår i: Clinical Psychology Review. - : Elsevier BV. - 0272-7358 .- 1873-7811. ; 80
-
Forskningsöversikt (refereegranskat)abstract
- PURPOSE: This study evaluated the effects of coping skills training (CST) on symptoms of depression and anxiety in cancer patients, and investigated moderators of the effects.METHODS: Overall effects and intervention-related moderators were studied in meta-analyses of pooled aggregate data from 38 randomized controlled trials (RCTs). Patient-related moderators were examined using linear mixed-effect models with interaction tests on pooled individual patient data (n = 1953) from 15 of the RCTs.RESULTS: CST had a statistically significant but small effect on depression (g = -0.31,95% confidence interval (CI) = -0.40;-0.22) and anxiety (g = -0.32,95%CI = -0.41;-0.24) symptoms. Effects on depression symptoms were significantly larger for interventions delivered face-to-face (p = .003), led by a psychologist (p = .02) and targeted to patients with psychological distress (p = .002). Significantly larger reductions in anxiety symptoms were found in younger patients (pinteraction < 0.025), with the largest reductions in patients <50 years (β = -0.31,95%CI = -0.44;-0.18) and no significant effects in patients ≥70 years. Effects of CST on depression (β = -0.16,95%CI = -0.25;-0.07) and anxiety (β = -0.24,95%CI = -0.33;-0.14) symptoms were significant in patients who received chemotherapy but not in patients who did not (pinteraction < 0.05).CONCLUSIONS: CST significantly reduced symptoms of depression and anxiety in cancer patients, and particularly when delivered face-to-face, provided by a psychologist, targeted to patients with psychological distress, and given to patients who were younger and received chemotherapy.
|
|
| 8. |
- Schreurs, G., et al.
(författare)
-
Analogue benchmarks of shortening and extension experiments
- 2006. - 253
-
Ingår i: <em> </em>Analogue and Numerical Modeling of Crustal-Scale Processes. - : Geological Society of London. - 1862391912 ; , s. 1-27
-
Bokkapitel (refereegranskat)abstract
- We report a direct comparison of scaled analogue experiments to test thereproducibility of model results among ten different experimental modelling laboratories.We present results for two experiments: a brittle thrust wedge experiment and a brittleviscousextension experiment. The experimental set-up, the model construction technique,the viscous material and the base and wall properties were prescribed. However, each laboratoryused its own frictional analogue material and experimental apparatus. Comparisonof results for the shortening experiment highlights large differences in model evolutionthat may have resulted from (1) differences in boundary conditions (indenter or basal-pullmodels), (2) differences in model widths, (3) location of observation (for example, sidewallversus centre of model), (4) material properties, (5) base and sidewall frictional properties,and (6) differences in set-up technique of individual experimenters. Six laboratories carriedout the shortening experiment with a mobile wall. The overall evolution of their models isbroadly similar, with the development of a thrust wedge characterized by forward thrustpropagation and by back thrusting. However, significant variations are observed inspacing between thrusts, their dip angles, number of forward thrusts and back thrusts, andsurface slopes. The structural evolution of the brittle-viscous extension experiments issimilar to a high degree. Faulting initiates in the brittle layers above the viscous layer in close vicinity to the basal velocity discontinuity. Measurements of fault dip angles and faultspacing vary among laboratories. Comparison of experimental results indicates an encouragingoverall agreement in model evolution, but also highlights important variations in thegeometry and evolution of the resulting structures that may be induced by differences inmodelling materials, model dimensions, experimental set-ups and observation location
|
|
| 9. |
|
|
| 10. |
- Vergouwen, Daphne P. C., et al.
(författare)
-
The enigma of sclera-specific autoimmunity in scleritis
- 2024
-
Ingår i: Journal of Autoimmunity. - : Elsevier. - 0896-8411 .- 1095-9157. ; 144
-
Tidskriftsartikel (refereegranskat)abstract
- Scleritis is a severe and painful ophthalmic disorder, in which a pathogenic role for collagen-directed autoimmunity was repeatedly suggested. We evaluated the presence of sclera-specific antibodies in a large cohort of patients with non-infectious scleritis. Therefore, we prospectively collected serum samples from 121 patients with non-infectious scleritis in a multicenter cohort study in the Netherlands. In addition, healthy (n = 39) and uveitis controls (n = 48) were included. Serum samples were tested for anti-native human type II collagen antibodies using a validated enzyme-linked immunosorbent assay (ELISA). Further, sclera-specific antibodies were determined using indirect immunofluorescence (IIF) on primate retinal/scleral cryosections. Lastly, human leukocyte antigen (HLA) typing was performed in 111 patients with scleritis. Anti-type II collagen antibodies were found in 13% of scleritis patients, in 10% of healthy controls and in 11% of uveitis controls (p = 0.91). A specific reaction to scleral nerve tissue on IIF was observed in 33% of patients with scleritis, which was higher than in healthy controls (11%; p = 0.01), but similar to uveitis controls (25%; p = 0.36). Reactivity to the scleral nerve tissue was significantly associated with earlier onset of scleritis (48 versus 56 years; p < 0.001), bilateral involvement (65% versus 42%; p = 0.01), and less frequent development of scleral necrosis (5% versus 22%; p = 0.02). HLA-B27 was found to be twice as prevalent in patients with scleritis (15.3%) compared to a healthy population (7.2%). In conclusion, scleral nerve autoantibody reactivity was more common in scleritis and uveitis patients in contrast to healthy controls. Further research is needed to characterize these scleral-nerve directed antibodies and assess their clinical value.
|
|
